Vilaiyuk, S., Lerkvaleekul, B., Soponkanaporn, S., Setthaudom, C., & Buranapraditkun, S. (2019). Correlations between serum interleukin 6, serum soluble interleukin 6 receptor, and disease activity in systemic juvenile idiopathic arthritis patients treated with or without tocilizumab. Cent Eur J Immunol.
Citación estilo ChicagoVilaiyuk, Soamarat, Butsabong Lerkvaleekul, Sirisucha Soponkanaporn, Chavachol Setthaudom, y Supranee Buranapraditkun. "Correlations between Serum Interleukin 6, Serum Soluble Interleukin 6 Receptor, and Disease Activity in Systemic Juvenile Idiopathic Arthritis Patients Treated With or Without Tocilizumab." Cent Eur J Immunol 2019.
Cita MLAVilaiyuk, Soamarat, et al. "Correlations between Serum Interleukin 6, Serum Soluble Interleukin 6 Receptor, and Disease Activity in Systemic Juvenile Idiopathic Arthritis Patients Treated With or Without Tocilizumab." Cent Eur J Immunol 2019.